Home » COVID-19 Vaccine » Page 5

COVID-19 Vaccine

Johnson & Johnson’s Single-Dose COVID-19 Vaccine Is 66% Effective Against The Virus

Source: SOPA Images / Getty A new weapon in the fight against COVID-19 is on the way. Friday (Jan.29), Johnson & Johnson shared some very promising news about its COVID-19 vaccine announcing that it prevents 85 percent of severe cases of the disease and “72% Effective in the US and 66% effective overall at preventing moderate to severe COVID-19, 28 Days after vaccination.” The most significant detail is that unlike Moderna and Pfizer / BioNTech’s COVID-19 vaccine, Johnson & Johnson’s vaccine only requires a single shot compared to two and doesn’t require it to be stored in extreme cold freezers. Also, unlike Pfizer / BioNTech and Moderna’s vaccine, which takes a genetic sample of the virus and inserts it into an oily bubble, Johnson & Johnson’s vaccine uses a gene from a snippe...

Tyler Perry Received Both Shots of Pfizer’s COVID-19 Vaccine To Help Boost Confidence In It

Source: Christopher Polk/E! Entertainment / Getty President Joe Biden is getting some help to fulfill his pledge to get 100,000,000 million American’s vaccinated against COVID-19 in his year one of his presidency, and it’s none other than Tyler Perry. Tyler Perry is here to spread the word that the vaccine is safe. The life-saving medicine arrived rather quickly, thanks to scientists and doctors working around the clock to find a vaccine to protect people from dying from COVD-19. Donald Trump and his poorly named private-public partnership, Operation Warp Speed, was created to help facilitate and ramp-up vaccine development and delivered on that part and gave much cause for concern regarding people willing to take the vaccine. Along with the Trump Administration’s poor lack of planning, Va...

Google Plans to Help Speed Up Delivery of Vaccines

Image sourced from Pymnts Google revealed that it will be giving $150 million to promote vaccine education and making it easier to find locally relevant COVID-19 information. The company is also going to use its technology to improve vaccine distribution. “The pandemic has taken a devastating toll on communities worldwide. While there is much uncertainty still ahead, the development of multiple safe vaccines in such a short time gives us reason for hope. Now the work begins to ensure that everyone can benefit from this triumph of scientific achievement, and quickly,” says Sundar Pichai, CEO of Google and Alphabet. To aid in the distribution, Google Cloud will help healthcare organizations, retail pharmacies, logistics companies, and public sector institutions make use of innovative technol...

Official: One million Americans vaccinated against coronavirus

More than a million people have received their first dose of a Covid-19 vaccine in the United States, Centers for Disease Control and Prevention (CDC) director Robert Redfield said Wednesday. “The United States achieved an early but important milestone today — jurisdictions have now reported that more than one million people have received their first dose of Covid-19 vaccine since administration began 10 days ago,” said Redfield. In a call with reporters, Moncef Slaoui, chief advisor of the government’s Operation Warp Speed, said that the objective of immunizing 20 million people this month was “unlikely to be met.” But he said the US was still aiming for 100 million people immunized by the end of the first quarter of 2021, and another 100 million by the second quarter. Three million doses...

Vietnam begins human trial of home-grown coronavirus vaccine

Human trials began on Thursday for Nanocovax, Vietnam’s first home-grown COVID-19 vaccine, a Director of a National Medical Research Centre said. “In the first phase, we will choose a group of 60 volunteers. This morning, we have finished vaccinating three people. “They will be monitored for three days, and if they remain in good condition, we will continue to vaccinate the rest.’’ Ho Anh Son, Deputy Director of the Military Medical Research Institute, told dpa. The trial is the first of three phases of testing for the vaccine. The second phase will involve testing on between 400 and 600 volunteers, according to the Health Ministry’s reports. Researchers told local media that an independent monitoring organisation will be hired to ensure the safety of volunteer participants and guarantee t...

First Americans vaccinated as U.S. death toll passes 300,000

An intensive care unit nurse became the first person in the United States to receive the Pfizer/BioNTech COVID-19 vaccine on Monday, calling it a sign that “healing is coming,” as the U.S. coronavirus death toll crossed a staggering 300,000 lives lost. Sandra Lindsay, who has treated some of the sickest COVID-19 patients for months, was given the vaccine at Long Island Jewish Medical Center in the New York City borough of Queens, an early epicenter of the country’s COVID-19 outbreak, receiving applause on a livestream with New York Governor Andrew Cuomo. “It didn’t feel any different from taking any other vaccine,” Lindsay said. “I feel hopeful today, relieved. I feel like healing is coming. I hope this marks the beginning of the end of a very painful time in our history. “I want to instil...

EU criticises ‘hasty’ UK approval of coronavirus vaccine

The European Union criticised Britain’s rapid approval of Pfizer and BioNTech’s COVID-19 vaccine on Wednesday, saying its own procedure was more thorough, after Britain became the first western country to endorse a COVID-19 shot. The move to grant emergency authorisation to the Pfizer/BioNTech vaccine has been seen by many as a political coup for UK Prime Minister Boris Johnson, who has led his country out of the EU and faced criticism for his handling of the pandemic. The decision was made under an ultra-fast, emergency approval process, which allowed the British drugs regulator to temporarily authorise the vaccine only ten days after it began examining data from large-scale trials. In an unusually blunt statement, the European Medicines Agency (EMA), which is in charge of approving COVID...

Spain touts mass vaccine plan, sees light at tunnel’s end

After months of turmoil and over 42,000 deaths, Spain appeared to see light at the end of the tunnel Friday, announcing ambitious plans to vaccinate much of the population by mid-2021. The post Spain touts mass vaccine plan, sees light at tunnel’s end appeared first on TODAY. You Deserve to Make Money Even When you are looking for Dates Online. So we reimagined what a dating should be. It begins with giving you back power. Get to meet Beautiful people, chat and make money in the process. Earn rewards by chatting, sharing photos, blogging and help give users back their fair share of Internet revenue.

Oil jumps 4 percent on upbeat coronavirus vaccine news

Global benchmark Brent crude rose 4.2 percent while US WTI jumped 4.6 percent after Moderna became the latest drug firm to release promising trial data on a COVID-19 vaccine. The post Oil jumps 4 percent on upbeat coronavirus vaccine news appeared first on TODAY. You Deserve to Make Money Even When you are looking for Dates Online. So we reimagined what a dating should be. It begins with giving you back power. Get to meet Beautiful people, chat and make money in the process. Earn rewards by chatting, sharing photos, blogging and help give users back their fair share of Internet revenue.

South Africa Begins First COVID-19 Vaccine Trial

Sourced from Getty Images The University of Witswatersrand has announced that South Africa’s first COVID-19 vaccine trial is set to begin, with participants to be enrolled by the end of the week. “This is a landmark moment for South Africa and Africa at this stage of the COVID-19 pandemic. As we enter winter in South Africa and pressure increases on public hospitals, now more than ever we need a vaccine to prevent infection by COVID-19,” Professor of Vaccinology at Wits University and Director of the South Africa Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Shabir Madhi, says in a virtual briefing. This new trial aims to find a vaccine that will prevent SARS-CoV-2 infection, which is the virus that causes COVID-19. “We began screening participants for ...